3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
6
Sarcoma
1
Other neoplasm
1
Breast
1
Conditions
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Leiomyoma
1
Endometriosis
1
Endometrial Neoplasms
1
Adenomyosis
1
Interventions
Colposcopy
5
Biopsy
3
Polymerase Chain Reaction
2
Imiquimod
2
human papillomavirus vaccine, TA
1
human papillomavirus vaccine, L1 type 16, 18
1
Zoledronic Acid
1
Watchful Waiting
1
Vaginal Smears
1
Tretinoin
1
Transurethral Resection of Prostate
1
Spectrum Analysis
1
Spectrometry, Fluorescence
1
Sodium Chloride
1
Robotic Surgical Procedures
1
Radiotherapy
1
Pregnancy Tests
1
Papanicolaou Test
1
Mindfulness-Based Stress Reduction
1
Microarray Analysis
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Human Papillomavirus DNA Tests
1
Histological Techniques
1
Folic Acid
1
Fluorophotometry
1
Flow Cytometry
1
Fenretinide
1
Eflornithine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Hysterectomy
×
Other neoplasm
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled